APA (7th ed.) Citation

Almeida, L., Rocha, J. F., Falcão, A., Nuno Palma, P., Loureiro, A. I., Pinto, R., . . . Soares-da-Silva, P. (2013). Pharmacokinetics, Pharmacodynamics and Tolerability of Opicapone, a Novel Catechol-O-Methyltransferase Inhibitor, in Healthy Subjects: Prediction of Slow Enzyme–Inhibitor Complex Dissociation of a Short-Living and Very Long-Acting Inhibitor. Clinical pharmacokinetics, 52(2), 139-151. https://doi.org/10.1007/s40262-012-0024-7

Chicago Style (17th ed.) Citation

Almeida, Luis, et al. "Pharmacokinetics, Pharmacodynamics and Tolerability of Opicapone, a Novel Catechol-O-Methyltransferase Inhibitor, in Healthy Subjects: Prediction of Slow Enzyme–Inhibitor Complex Dissociation of a Short-Living and Very Long-Acting Inhibitor." Clinical Pharmacokinetics 52, no. 2 (2013): 139-151. https://doi.org/10.1007/s40262-012-0024-7.

MLA (9th ed.) Citation

Almeida, Luis, et al. "Pharmacokinetics, Pharmacodynamics and Tolerability of Opicapone, a Novel Catechol-O-Methyltransferase Inhibitor, in Healthy Subjects: Prediction of Slow Enzyme–Inhibitor Complex Dissociation of a Short-Living and Very Long-Acting Inhibitor." Clinical Pharmacokinetics, vol. 52, no. 2, 2013, pp. 139-151, https://doi.org/10.1007/s40262-012-0024-7.